Skip to Content

Vilanterol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R03AL03

CAS registry number (Chemical Abstracts Service)

0503068-34-6

Chemical Formula

C24-H33-Cl2-N-O5

Molecular Weight

486

Therapeutic Categories

Antiasthmatic agent

β₂-Sympathomimetic agent

Treatment of asthma and COPD

Chemical Name

4-{(1R)-2-[(6-{2-[(2,6-dichlorophenyl)metoxy]etoxy}hexyl)amino]-1-hydroxyetyl}-2-(hydroxymetyl)phenol (WHO)

Foreign Names

  • Vilanterolum (Latin)
  • Vilanterol (German)
  • Vilantérol (French)
  • Vilanterol (Spanish)

Generic Names

  • Vilanterol (OS: USAN)
  • GW 642444X (IS)
  • UNII-028LZY775B (IS)
  • Vilanterol Trifenatate (OS: USAN, JAN)
  • GW 642444M (IS)
  • UNII-40AHO2C6DG (IS)

Brand Names

  • Anoro (Vilanterol and Umeclidinium Bromide)
    Glaxo Group, Poland; GlaxoSmithKline, Slovakia; Wellcome Limited, Bosnia & Herzegowina
  • Anoro (Vilanterol and Umeclidinium)
    Glaxo Operations UK, Macedonia; GlaxoSmithKline, Chile
  • Anoro Ellipta (Vilanterol and Umeclidinium)
    GlaxoSmithKline, United States
  • Laventair (Vilanterol and Umeclidinium Bromide)
    Glaxo Group, Poland
  • Relvar Ellipta (Vilanterol and Fluticasone)
    Glaxo Group, Poland; Glaxo Group, Romania; GlaxoSmithKline, Chile; GlaxoSmithKline, Germany; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Italy; GlaxoSmithKline, Latvia; GlaxoSmithKline, Portugal; GlaxoSmithKline, Slovakia; GlaxoSmithKline Laboratoire Pharmaceutique, France; Wellcome Limited, Bosnia & Herzegowina
  • Revinty Ellipta (Vilanterol and Fluticasone)
    Glaxo Group, Poland
  • Anoro (Vilanterol and Umeclidinium Bromide)
    Glaxo Group, Cyprus
  • Anoro (Vilanterol and Umeclidinium)
    Glaxo Group, Austria; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Sweden; GlaxoSmithKline, United States; GSK, Belgium
  • Anoro Ellipta (Vilanterol and Umeclidinium)
    GlaxoSmithKline, Canada; GlaxoSmithKline UK, United Kingdom
  • Breo Ellipta (Vilanterol and Fluticasone)
    GlaxoSmithKline, Canada; GlaxoSmithKline, United States
  • Relvar Ellipta (Vilanterol and Fluticasone)
    Glaxo Group, Austria; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Japan; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; GlaxoSmithKline UK, United Kingdom; GSK, Belgium
  • Relvare (Vilanterol and Fluticasone)
    GlaxoSmithKline, Mexico

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide